242 related articles for article (PubMed ID: 14975186)
1. Viral interleukin-10-engineered autologous hematopoietic stem cell therapy: a novel gene therapy approach to prevent graft rejection.
Salgar SK; Yang D; Ruiz P; Miller J; Tzakis AG
Hum Gene Ther; 2004 Feb; 15(2):131-44. PubMed ID: 14975186
[TBL] [Abstract][Full Text] [Related]
2. Viral interleukin-10 gene therapy to induce tolerance to solid organ transplants in mice.
Salgar SK; Yang D; Ruiz P; Miller J; Tzakis AG
Transplant Proc; 2004 Mar; 36(2):397-8. PubMed ID: 15050171
[TBL] [Abstract][Full Text] [Related]
3. [Transfection with virus interleukin-10 to prolong murine heart allograft].
Yang DH; Wu MC; Peng MH; Tzakis A
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):87-91. PubMed ID: 15771810
[TBL] [Abstract][Full Text] [Related]
4. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
[TBL] [Abstract][Full Text] [Related]
5. Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses.
DeBruyne LA; Li K; Chan SY; Qin L; Bishop DK; Bromberg JS
Gene Ther; 1998 Aug; 5(8):1079-87. PubMed ID: 10326031
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury.
Manning E; Pham S; Li S; Vazquez-Padron RI; Mathew J; Ruiz P; Salgar SK
Hum Gene Ther; 2010 Jun; 21(6):713-27. PubMed ID: 20102275
[TBL] [Abstract][Full Text] [Related]
7. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors.
Suzuki T; Tahara H; Narula S; Moore KW; Robbins PD; Lotze MT
J Exp Med; 1995 Aug; 182(2):477-86. PubMed ID: 7629507
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival.
Qin L; Chavin KD; Ding Y; Tahara H; Favaro JP; Woodward JE; Suzuki T; Robbins PD; Lotze MT; Bromberg JS
J Immunol; 1996 Mar; 156(6):2316-23. PubMed ID: 8690923
[TBL] [Abstract][Full Text] [Related]
9. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10.
Qin L; Chavin KD; Ding Y; Favaro JP; Woodward JE; Lin J; Tahara H; Robbins P; Shaked A; Ho DY
Transplantation; 1995 Mar; 59(6):809-16. PubMed ID: 7701573
[TBL] [Abstract][Full Text] [Related]
10. Viral IL-10-induced immunosuppression requires Th2 cytokines and impairs APC function within the allograft.
Qin L; Ding Y; Tahara H; Bromberg JS
J Immunol; 2001 Feb; 166(4):2385-93. PubMed ID: 11160297
[TBL] [Abstract][Full Text] [Related]
11. Viral IL-10 gene transfer prolongs rat islet allograft survival.
Kim YH; Lim DG; Wee YM; Kim JH; Yun CO; Choi MY; Park YH; Kim SC; Han DJ
Cell Transplant; 2008; 17(6):609-18. PubMed ID: 18819249
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection.
Zhao J; Pettigrew GJ; Bolton EM; Murfitt CR; Carmichael A; Bradley JA; Lever AM
Gene Ther; 2005 Oct; 12(20):1509-16. PubMed ID: 15858608
[TBL] [Abstract][Full Text] [Related]
13. Human interleukin-10 transduced fetal liver stem cells prolong survival of mouse skin and heart allografts.
Hase T; Chargui J; Inori F; Yoshimura R; Sembeil R; Nakatani T; Touraine JL
Transplant Proc; 2005; 37(1):287-8. PubMed ID: 15808621
[TBL] [Abstract][Full Text] [Related]
14. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection.
Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC
Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival.
Huang BJ; Yin H; Huang YF; Xu JF; Xiong P; Feng W; Zheng F; Xu Y; Fang M; Gong FL
Transpl Immunol; 2006 Aug; 16(2):88-94. PubMed ID: 16860710
[TBL] [Abstract][Full Text] [Related]
16. Prope tolerance to heart allografts in mice associated with persistence of donor interleukin-10-transduced stem cells.
Brikci-Nigassa L; Matsuyama M; Hase T; Eljaafari A; Chargui J; Sanhadji K; Inori F; Nakatani T; Yoshimura R; Touraine JL
Transplantation; 2012 Apr; 93(8):761-8. PubMed ID: 22487811
[TBL] [Abstract][Full Text] [Related]
17. CTLA4-Ig-based conditioning regimen to induce tolerance to cardiac allografts.
Li S; Salgar SK; Thanikachalam M; Murdock AD; Gammie JS; Demetris AJ; Zeevi A; Pham SM
J Surg Res; 2006 Dec; 136(2):238-46. PubMed ID: 17046021
[TBL] [Abstract][Full Text] [Related]
18. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
[TBL] [Abstract][Full Text] [Related]
20. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
